⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novi Weight Loss GLP-1 Program (2026): What 50,000 People Searching This Brand Need to Know Before Enrolling
accessnewswire.com
NVO
LLY
Novo Nordisk's Wegovy® HD available now nationwide
prnewswire.com
NVO
Novo Nordisk A/S – Share repurchase programme
globenewswire.com
NVO
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll
accessnewswire.com
NVO
LLY
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
businesswire.com
NVO
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 USA - English USA - English
prnewswire.com
NVO
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
globenewswire.com
NVO
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 USA - English USA - English
prnewswire.com
NVO
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
prnewswire.com
LLY
NVO
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
globenewswire.com
NVO
LLY
PFE
ABBV